Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene

Sigrid E. Berg; Lisa H. Downs; Drew A. Torigian; Elise A. Chong; Donald E. Tsai; Mariusz A. Wasik; Stephen J. Schuster

doi:10.4161/cbt.7.10.6834

Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene

Sigrid E. Berg, Lisa H. Downs, Drew A. Torigian, Elise A. Chong, Donald E. Tsai, Mariusz A. Wasik, Stephen J. Schuster

University of Pennsylvania

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Lymphomatoid granulomatosis is a rare lymphoproliferative disorder involving the lungs, skin and other organs. Advanced-stage disease does not tend to respond well to cytotoxic chemotherapy and is associated with a poor prognosis. We present a case of successful treatment of relapsed lymphomatoid granulomatosis with bexarotene, a novel retinoid agent.

Original language	English
Pages (from-to)	1544-1546
Number of pages	3
Journal	Cancer Biology and Therapy
Volume	7
Issue number	10
DOIs	https://doi.org/10.4161/cbt.7.10.6834
State	Published - Oct 2008
Externally published	Yes

Keywords

Bexarotene
Lymphomatoid granulomatosis
Lymphoproliferative disease
New drugs for lymphoma
Novel therapeutics
Retinoid
T-cell lymphoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/cbt.7.10.6834

Cite this

@article{292fca99c8a146c0ad1eefba23caf74a,

title = "Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene",

abstract = "Lymphomatoid granulomatosis is a rare lymphoproliferative disorder involving the lungs, skin and other organs. Advanced-stage disease does not tend to respond well to cytotoxic chemotherapy and is associated with a poor prognosis. We present a case of successful treatment of relapsed lymphomatoid granulomatosis with bexarotene, a novel retinoid agent.",

keywords = "Bexarotene, Lymphomatoid granulomatosis, Lymphoproliferative disease, New drugs for lymphoma, Novel therapeutics, Retinoid, T-cell lymphoma",

author = "Berg, {Sigrid E.} and Downs, {Lisa H.} and Torigian, {Drew A.} and Chong, {Elise A.} and Tsai, {Donald E.} and Wasik, {Mariusz A.} and Schuster, {Stephen J.}",

year = "2008",

month = oct,

doi = "10.4161/cbt.7.10.6834",

language = "English",

volume = "7",

pages = "1544--1546",

journal = "Cancer Biology and Therapy",

issn = "1538-4047",

publisher = "Taylor and Francis Ltd.",

number = "10",

}

TY - JOUR

T1 - Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene

AU - Berg, Sigrid E.

AU - Downs, Lisa H.

AU - Torigian, Drew A.

AU - Chong, Elise A.

AU - Tsai, Donald E.

AU - Wasik, Mariusz A.

AU - Schuster, Stephen J.

PY - 2008/10

Y1 - 2008/10

N2 - Lymphomatoid granulomatosis is a rare lymphoproliferative disorder involving the lungs, skin and other organs. Advanced-stage disease does not tend to respond well to cytotoxic chemotherapy and is associated with a poor prognosis. We present a case of successful treatment of relapsed lymphomatoid granulomatosis with bexarotene, a novel retinoid agent.

AB - Lymphomatoid granulomatosis is a rare lymphoproliferative disorder involving the lungs, skin and other organs. Advanced-stage disease does not tend to respond well to cytotoxic chemotherapy and is associated with a poor prognosis. We present a case of successful treatment of relapsed lymphomatoid granulomatosis with bexarotene, a novel retinoid agent.

KW - Bexarotene

KW - Lymphomatoid granulomatosis

KW - Lymphoproliferative disease

KW - New drugs for lymphoma

KW - Novel therapeutics

KW - Retinoid

KW - T-cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=54349111616&partnerID=8YFLogxK

U2 - 10.4161/cbt.7.10.6834

DO - 10.4161/cbt.7.10.6834

M3 - Article

C2 - 18836291

AN - SCOPUS:54349111616

SN - 1538-4047

VL - 7

SP - 1544

EP - 1546

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

IS - 10

ER -

Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this